Concord Medical Services Holdings Ltd (CCM)

$7.9

-0.66

(-7.71%)▲

Market is closed - opens 7 PM, 18 Oct 2024

Performance

  • $7.79
    $8.40
    $7.90
    downward going graph

    1.34%

    Downside

    Day's Volatility :7.21%

    Upside

    5.95%

    downward going graph
  • $3.82
    $26.70
    $7.90
    downward going graph

    51.67%

    Downside

    52 Weeks Volatility :85.7%

    Upside

    70.41%

    downward going graph

Returns

PeriodConcord Medical Services Holdings LtdIndex (Russel 2000)
3 Months
1.06%
0.0%
6 Months
46.78%
0.0%
1 Year
-17.69%
0.0%
3 Years
-68.06%
-21.9%

Highlights

Market Capitalization
37.2M
Book Value
-$489.59
Earnings Per Share (EPS)
-14.19
PEG Ratio
0.0
Wall Street Target Price
1.2
Profit Margin
-80.33%
Operating Margin TTM
-90.37%
Return On Assets TTM
-4.4%
Return On Equity TTM
-32.4%
Revenue TTM
471.7M
Revenue Per Share TTM
107.98
Quarterly Revenue Growth YOY
-23.1%
Gross Profit TTM
-152.4M
EBITDA
-330.1M
Diluted Eps TTM
-14.19
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Sell
    0
    0%Buy
    25%Hold
    75%Sell
Based on 8 Wall street analysts offering stock ratings for Concord Medical Services Holdings Ltd(by analysts ranked 0 to 5 stars)
Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
00
00
00
Hold
2
2
2
Sell
6
6
6

Analyst Forecast

What analysts predicted

Downside of 84.81%

Current $7.90
Target $1.20

Company Financials

FY18Y/Y Change
Revenue
27.7M
↓ 42.32%
Net Income
-34.1M
↓ 17.39%
Net Profit Margin
-123.04%
↓ 37.14%
FY19Y/Y Change
Revenue
28.3M
↑ 3.91%
Net Income
-50.2M
↑ 49.91%
Net Profit Margin
-177.5%
↓ 54.46%
FY20Y/Y Change
Revenue
34.1M
↑ 12.43%
Net Income
-61.8M
↑ 14.75%
Net Profit Margin
-181.17%
↓ 3.67%
FY21Y/Y Change
Revenue
76.3M
↑ 117.76%
Net Income
-128.9M
↑ 103.11%
Net Profit Margin
-168.98%
↑ 12.19%
FY22Y/Y Change
Revenue
67.7M
↓ 2.79%
Net Income
-70.2M
↓ 40.33%
Net Profit Margin
-103.72%
↑ 65.26%
FY23Y/Y Change
Revenue
75.3M
↑ 13.84%
Net Income
-41.7M
↓ 39.21%
Net Profit Margin
-55.39%
↑ 48.33%
Q1 FY23Q/Q Change
Revenue
20.6M
-
Net Income
-6.6M
-
Net Profit Margin
-31.98%
-
Q2 FY23Q/Q Change
Revenue
5.7M
↓ 71.14%
Net Income
-6.4M
↑ 0.0%
Net Profit Margin
-110.82%
↓ 78.84%
Q3 FY23Q/Q Change
Revenue
126.4M
↑ 208.03%
Net Income
-103.3M
↑ 127.15%
Net Profit Margin
-81.72%
↑ 29.1%
Q1 FY24Q/Q Change
Revenue
34.9M
↓ 72.37%
Net Income
-103.3M
↑ 0.0%
Net Profit Margin
-295.75%
↓ 214.03%
Q2 FY24Q/Q Change
Revenue
30.3M
↓ 13.21%
Net Income
-23.9M
↓ 76.9%
Net Profit Margin
-78.72%
↑ 217.03%
FY18Y/Y Change
Total Assets
665.6M
↑ 32.32%
Total Liabilities
335.5M
↓ 5.67%
FY19Y/Y Change
Total Assets
612.7M
↓ 6.28%
Total Liabilities
343.4M
↑ 4.18%
FY20Y/Y Change
Total Assets
815.6M
↑ 24.13%
Total Liabilities
448.5M
↑ 21.82%
FY21Y/Y Change
Total Assets
978.3M
↑ 16.79%
Total Liabilities
547.4M
↑ 18.83%
FY22Y/Y Change
Total Assets
860.5M
↓ 3.61%
Total Liabilities
571.7M
↑ 14.43%
FY23Y/Y Change
Total Assets
847.8M
↑ 0.82%
Total Liabilities
603.1M
↑ 7.96%
Q1 FY23Q/Q Change
Total Assets
880.6M
↑ 1.08%
Total Liabilities
577.7M
↓ 0.18%
Q2 FY23Q/Q Change
Total Assets
847.4M
↑ 0.0%
Total Liabilities
555.9M
↑ 0.0%
Q3 FY23Q/Q Change
Total Assets
6.1B
↓ 0.27%
Total Liabilities
4.3B
↑ 8.16%
Q4 FY23Q/Q Change
Total Assets
847.8M
↑ 0.0%
Total Liabilities
603.1M
↑ 0.0%
Q1 FY24Q/Q Change
Total Assets
6.6B
↑ 9.39%
Total Liabilities
4.7B
↑ 9.17%
Q2 FY24Q/Q Change
Total Assets
6.6B
↑ 0.0%
Total Liabilities
4.7B
↑ 0.0%
FY18Y/Y Change
Operating Cash Flow
-5.6M
↓ 244.36%
Investing Cash Flow
-145.2M
↑ 219.59%
Financing Cash Flow
174.6M
↑ 518.83%
FY19Y/Y Change
Operating Cash Flow
-27.9M
↑ 406.2%
Investing Cash Flow
-152.8M
↑ 7.11%
Financing Cash Flow
73.2M
↓ 57.34%
FY20Y/Y Change
Operating Cash Flow
-35.1M
↑ 17.62%
Investing Cash Flow
-81.6M
↓ 50.17%
Financing Cash Flow
174.0M
↑ 121.78%
FY21Y/Y Change
Operating Cash Flow
-56.4M
↑ 56.38%
Investing Cash Flow
-88.9M
↑ 6.01%
Financing Cash Flow
100.9M
↓ 43.56%
FY22Y/Y Change
Operating Cash Flow
-31.1M
↓ 39.69%
Investing Cash Flow
-17.0M
↓ 79.01%
Financing Cash Flow
54.9M
↓ 40.37%
Q2 FY19Q/Q Change
Operating Cash Flow
0.0
↓ 100.0%
Investing Cash Flow
0.0
-
Financing Cash Flow
0.0
↓ 100.0%

Technicals Summary

Sell

Neutral

Buy

Concord Medical Services Holdings Ltd is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Concord Medical Services Holdings Ltd
Concord Medical Services Holdings Ltd
48.35%
46.78%
-17.69%
-68.06%
-63.65%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
-4.07%
5.59%
14.79%
-42.95%
-41.31%
Hca Holdings, Inc.
Hca Holdings, Inc.
2.95%
31.57%
67.74%
65.96%
233.25%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
4.5%
70.86%
190.37%
160.49%
598.0%
Universal Health Services Inc.
Universal Health Services Inc.
1.99%
48.03%
86.05%
78.73%
61.93%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
0.37%
29.13%
115.79%
47.37%
184.91%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Concord Medical Services Holdings Ltd
Concord Medical Services Holdings Ltd
NA
NA
0.0
0.0
-0.32
-0.04
NA
-489.59
Fresenius Medical Care Ag
Fresenius Medical Care Ag
20.23
20.23
0.41
2.52
0.05
0.03
0.03
47.48
Hca Holdings, Inc.
Hca Holdings, Inc.
19.2
19.2
1.21
22.62
0.74
0.11
0.01
-6.17
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
5.97
5.97
0.82
10.57
0.55
0.07
NA
36.27
Universal Health Services Inc.
Universal Health Services Inc.
17.41
17.41
1.87
15.93
0.15
0.06
0.0
97.21
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
17.51
17.51
1.5
9.8
0.45
0.07
NA
7.44
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Concord Medical Services Holdings Ltd
Concord Medical Services Holdings Ltd
Sell
$37.2M
-63.65%
NA
-80.33%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
Hold
$11.8B
-41.31%
20.23
2.73%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$105.6B
233.25%
19.2
8.4%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
Buy
$15.7B
598.0%
5.97
13.18%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$15.8B
61.93%
17.41
6.22%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$13.8B
184.91%
17.51
6.86%

Insights on Concord Medical Services Holdings Ltd

  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 126.44M → 30.32M (in $), with an average decrease of 42.8% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -103.33M → -23.87M (in $), with an average increase of 332.9% per quarter

  • Vs THC

    In the last 1 year, Tenet Healthcare Corp.  has given 190.4% return, outperforming this stock by 208.1%

  • Vs THC

    In the last 3 years, Tenet Healthcare Corp.  has given 158.1% return, outperforming this stock by 227.0%

Institutional Holdings

  • Renaissance Technologies Corp

    0.09%

  • Rhumbline Advisers

    0.01%

Company Information

concord medical services holdings limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the people's republic of china. the company operates in network and hospital segments. the company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. it also offers other treatments and diagnostic services comprising electroencephalography for the diagnosis of epilepsy; thermotherapy for pain relief after radiotherapy and chemotherapy; ultrasound therapy for the treatment of cancer; stereotactic radiofrequency ablation for the treatment of parkinson's disease; and refraction and tonometry for the diagnosis of ophthalmic conditions. in addition, the company provides clinical support services, including developing treatment protocols for doctors; and organizing joint diagnosis between doctors in its network and clinical resear

Organization
Concord Medical Services Holdings Ltd
Employees
727
CEO
Dr. Jianyu Yang
Industry
Health Services

Discover More

FAQs